Language：English   Publishing type：Research paper (scientific journal)  

INTRODUCTION: This study aimed to elucidate the prevalence and clinical characteristics of patients with long COVID (coronavirus disease 2019), especially focusing on 50% hemolytic complement activity (CH50). METHODS: This retrospective observational study focused on patients who visited Okayama University Hospital (Japan) for the treatment of long COVID between February 2021 and March 2023. CH50 levels were measured using liposome immunometric assay (Autokit CH50 Assay, FUJIFILM Wako Pure Chemical Corporation, Japan); high CH50 was defined as ≥59 U/mL. Univariate analyses assessed differences in the clinical background, long COVID symptoms, inflammatory markers, and clinical scores of patients with normal and high CH50. Logistic regression model investigated the association between high CH50 levels and these factors. RESULTS: Of 659 patients who visited our hospital, 478 patients were included. Of these, 284 (59.4%) patients had high CH50 levels. Poor concentration was significantly more frequent in the high CH50 group (7.2% vs. 13.7%), whereas no differences were observed in other subjective symptoms (fatigue, headache, insomnia, dyspnea, tiredness, and brain fog). Multivariate analysis was performed on factors that could be associated with poor concentration, suggesting a significant relationship to high CH50 levels (adjusted odds ratio [aOR], 2.70; 95% confidence interval [CI], 1.33-5.49). Also, high CH50 was significantly associated with brain fog (aOR, 1.66; 95% CI, 1.04-2.66). CONCLUSIONS: High CH50 levels were frequently reported in individuals with long COVID, indicating a relationship with brain fog. Future in-depth research should examine the pathological role and causal link between complement immunity and the development of long COVID.

DOI： 10.1016/j.jiac.2023.10.016

PubMed

researchmap

Publishing type：Research paper (scientific journal)   Publisher：MDPI AG  

Orexins are neuropeptides that play important roles in sleep-wake regulation and food intake in the central nervous system, but their receptors are also expressed in peripheral tissues, including the endocrine system. In the present study, we investigated the functions of orexin in adrenal steroidogenesis using human adrenocortical H295R cells by focusing on its interaction with adrenocortical bone morphogenetic proteins (BMPs) that induce adrenocortical steroidogenesis. Treatment with orexin A increased the mRNA levels of steroidogenic enzymes including StAR, CYP11B2, CYP17, and HSD3B1, and these effects of orexin A were further enhanced in the presence of forskolin. Interestingly, orexin A treatment suppressed the BMP-receptor signaling detected by Smad1/5/9 phosphorylation and Id-1 expression through upregulation of inhibitory Smad7. Orexin A also suppressed endogenous BMP-6 expression but increased the expression of the type-II receptor of ActRII in H295R cells. Moreover, treatment with BMP-6 downregulated the mRNA level of OX1R, but not that of OX2R, expressed in H295R cells. In conclusion, the results indicate that both orexin and BMP-6 accelerate adrenocortical steroidogenesis in human adrenocortical cells; both pathways mutually inhibit each other, thereby leading to a fine-tuning of adrenocortical steroidogenesis.

DOI： 10.3390/ijms241612559

researchmap

Language：English   Publishing type：Research paper (scientific journal)  

OBJECTIVE: The most common symptom of post-acute coronavirus disease 2019 (COVID-19) is fatigue, and it potentially leads to myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS); however, a specific prognosticator is lacking. We aimed to elucidate the clinical characteristics of patients who developed ME/CFS after COVID-19. METHODS: In this retrospective observational study, patients who visited Okayama University Hospital for long COVID between February 2021 and March 2022 were investigated. RESULTS: Of the 234 patients, 139 (59.4%) had fatigue symptoms. Fifty patients with fatigue symptoms (21.4%) met the criteria for ME/CFS (ME/CFS group), while the other 89 patients did not (non-ME/CFS group); 95 patients had no fatigue complaints (no-fatigue group). Although the patients' backgrounds were not significantly different between the three groups, the ME/CFS group presented the highest scores on the self-rating symptom scales, including the Fatigue Assessment Scale (FAS), EuroQol, and the Self-Rating Depression Scale (SDS). Furthermore, serum ferritin levels, which were correlated with FAS and SDS scores, were significantly higher in the ME/CFS group (193.0 μg/L, interquartile range (IQR): 58.8-353.8) than in the non-ME/CFS group (98.2 μg/L, 40.4-251.5) and no-fatigue group (86.7 μg/L, 37.5-209.0), and a high serum ferritin level was prominent in female patients. Endocrine workup further showed that the ME/CFS group had higher thyrotropin levels but lower growth hormone levels in serum and that insulin-like growth factor-I levels were inversely correlated with ferritin levels (R = -0.328, p < 0.05). CONCLUSIONS: Serum ferritin level is a possible predictor of the development of ME/CFS related to long COVID, especially in female patients.

DOI： 10.3390/jcm12144737

PubMed

researchmap

Language：Japanese   Publisher：(一社)日本医学教育学会  

researchmap

Language：English   Publishing type：Research paper (scientific journal)  

Objectives: The present study aimed to elucidate the characteristics of long COVID patients with headaches. Methods: A single-center retrospective observational study was performed for long COVID outpatients who visited our hospital from 12 February 2021 to 30 November 2022. Results: A total of 482 long COVID patients, after excluding 6, were divided into two groups: the Headache group of patients with complaints of headache (113 patients: 23.4%) and the remaining Headache-free group. Patients in the Headache group were younger (median age: 37 years) than patients in the Headache-free group (42 years), while the ratio of females (56%) in the Headache group was nearly the same as that in the Headache-free group (54%). The proportion of patients in the Headache group who were infected in the Omicron-dominant phase (61%) was larger than the proportions of patients infected in the Delta (24%) and preceding (15%) phases, and that trend was significantly different from the trend in the Headache-free group. The duration before the first visit for long COVID was shorter in the Headache group (71 days) than in the Headache-free group (84 days). The proportions of patients in the Headache group with comorbid symptoms, including general fatigue (76.1%), insomnia (36.3%), dizziness (16.8%), fever (9.7%), and chest pain (5.3%) were larger than the proportions of patients in the Headache-free group, whereas blood biochemical data were not significantly different between the two groups. Interestingly, patients in the Headache group had significant deteriorations of scores indicating depression and scores for quality of life and general fatigue. In multivariate analysis, headache, insomnia, dizziness, lethargy, and numbness were shown to be involved in the quality of life (QOL) of long COVID patients. Conclusions: The manifestation of headaches related to long COVID was found to have a significant impact on social and psychological activities. Alleviation of headaches should be a priority for the effective treatment of long COVID.

DOI： 10.3390/jcm12103533

PubMed

researchmap

Publishing type：Research paper (scientific journal)   Publisher：Elsevier BV  

DOI： 10.1016/j.bbrc.2023.05.058

researchmap

Language：English   Publishing type：Research paper (scientific journal)  

OBJECTIVES: The aim of this study was to determine the characteristics of hypozincemia in long COVID patients. METHODS: This study was a single-center retrospective observational study for outpatients who visited the long COVID clinic established in a university hospital during the period from 15 February 2021 to 28 February 2022. Characteristics of patients with a serum zinc concentration lower than 70 μg/dL (10.7 μmol/L) were compared with characteristics of patients with normozincemia. RESULTS: In a total of 194 patients with long COVID after excluding 32 patients, hypozincemia was detected in 43 patients (22.2%) including 16 male patients (37.2%) and 27 female patients (62.8%). Among various parameters including the background characteristics of the patients and medical histories, the patients with hypozincemia were significantly older than the patients with normozincemia (median age: 50 vs. 39 years). A significant negative correlation was found between serum zinc concentrations and age in male patients (R = -0.39; p < 0.01) but not in female patients. In addition, there was no significant correlation between serum zinc levels and inflammatory markers. General fatigue was the most frequent symptom in both male patients with hypozincemia (9 out of 16: 56.3%) and female patients with hypozincemia (8 out of 27: 29.6%). Patients with severe hypozincemia (serum zinc level lower than 60 μg/dL) had major complaints of dysosmia and dysgeusia, which were more frequent complaints than general fatigue. CONCLUSIONS: The most frequent symptom in long COVID patients with hypozincemia was general fatigue. Serum zinc levels should be measured in long COVID patients with general fatigue, particularly in male patients.

DOI： 10.3390/jcm12052062

PubMed

researchmap

Language：Japanese   Publisher：(一社)日本感染症学会  

症例は30歳代ネパール人男性で、下痢と嘔気を主訴とした。ハンセン病(LL型)と新型コロナウイルス感染症の既往があり、らい反応に対して長期間のステロイド製剤内服による免疫抑制療法を行っていた。各種検査所見より、糞線虫の過剰感染状態による播種性糞線虫症と診断した。栄養状態は不良で、寄生虫の消化管内過剰増殖に伴う腸管浮腫を認め、イベルメクチンは吸収不良で血中濃度が不十分であった。多臓器不全を併発したため集学的治療を行ったが第36病日に死亡した。日本では糞線虫症は稀であるが、インバウンドの増加に伴い播種性糞線虫症のリスクが増加する可能性があり、ステロイドの長期内服などで免疫抑制状態の可能性がある場合は寄生虫スクリーニングを行う必要があると考えられた。

researchmap

Language：English   Publishing type：Research paper (scientific journal)  

Background: Since the start of the global pandemic of coronavirus disease 2019 (COVID-19), not only adults but also many children have suffered from it. However, the clinical characteristics of long COVID in children remain unclear. Methods: In this retrospective observational study conducted in a single facility, we reviewed the medical records of all long COVID patients who visited Okayama University Hospital from February 2021 to October 2022, and we compared the clinical characteristics of long COVID in teenagers (11 to 18 years of age) with those in adults. Results: Data for 452 long COVID patients including 54 teenagers (11.9%) were analyzed. Fatigue was the most frequent symptom in teenagers (55.6% of the patients) and also in adults. On the other hand, the percentage of teenagers who complained of headache, which was the second most frequent complaint, was significantly higher than the percentage of adults (35.2% vs. 21.9%, p < 0.05). A comparison of the frequencies of symptoms depending on the viral variant showed that fatigue and headache were predominant symptoms in the Omicron variant phase. Of the 50 teenagers who were enrolled in schools, 28 (56.0%) could not attend school due to long COVID symptoms. The most common symptoms as reasons for absence from school were fatigue (85.7% of the patients), headache (42.9%), and insomnia (32.1%). Conclusions: Attention should be paid to the symptoms of fatigue and headache in teenagers with long COVID.

DOI： 10.3390/medicina59020261

PubMed

researchmap

Publishing type：Research paper (scientific journal)   Publisher：Elsevier BV  

DOI： 10.1016/j.bbrc.2023.01.073

researchmap

Publishing type：Research paper (scientific journal)   Publisher：Elsevier BV  

DOI： 10.1016/j.idcr.2023.e01733

researchmap

Language：English   Publishing type：Research paper (scientific journal)  

OBJECTIVES: The objective of this study was to determine the clinical and endocrinological features of sleep disturbance in patients with long COVID. METHODS: This study was a single-center retrospective observational study for patients who visited the COVID-19 aftercare outpatient clinic (CAC) established in Okayama University Hospital in Japan during the period from 15 February 2021 to 29 July 2022. The long COVID patients were divided into two groups based on the presence or absence of sleep disturbance, and the clinical and laboratory characteristics of the patients were analyzed. RESULTS: Out of 363 patients with long COVID, after excluding 6 patients, 60 patients (16.5%) (55% males, median age of 38 years) complaining of sleep disturbance were compared with 303 patients (83.5%) (43% males, median age of 40 years) without sleep-related symptoms. Although there were no significant differences in clinical backgrounds and severities of COVID-19 between the two groups by the multivariate analysis, the percentage of long COVID patients with sleep disturbance was significantly increased among patients infected in the Omicron-dominant phase. In addition, the prevalence rate of sleep disturbance in patients when infected in the Omicron phase (24.8%) was two-times higher than that in patients infected in the Delta phase (12.8%). Of note, the percentages of patients with sleep disturbance who also complained of general fatigue, headache, concentration loss, anxiety, low-grade fever, and brain fog symptoms were higher than the percentages of patients without sleep disturbance who had the same complaints. Among the types of sleep disturbance, the percentage of patients who complained of loss of sleep induction (75%) was much higher than the percentage of patients with early-awakening sleep disturbance (6.7%), and many of the patients with mid-awakening types of insomnia had brain fog symptoms. Endocrine examinations revealed that long COVID patients with sleep disturbance had significantly higher levels of plasma adrenocorticotropin and lower levels of serum growth hormone, suggesting the presence of hypothalamic-pituitary stress. CONCLUSION: The prevalence of sleep disturbance has been increasing in long COVID patients infected in the Omicron phase with a certain clinical and endocrine trend.

DOI： 10.3390/jcm11247332

PubMed

researchmap

Language：English   Publishing type：Research paper (scientific journal)   Publisher：Springer Science and Business Media LLC  

Abstract

Amid the Coronavirus Disease 2019 pandemic, we aimed to demonstrate the accuracy of the fingertip whole blood sampling test (FWT) in measuring the antibody titer and uncovering its dynamics shortly after booster vaccination. Mokobio SARS-CoV-2 IgM &amp; IgG Quantum Dot immunoassay (Mokobio Biotechnology R&amp;D Center Inc., MD, USA) was used as a point-of-care FWT in 226 health care workers (HCWs) who had received two doses of the BNT162b2 mRNA vaccine (Pfizer-BioNTech) at least 8 months prior. Each participant tested their antibody titers before and after the third-dose booster up to 14-days. The effect of the booster was observed as early as the fourth day after vaccination, which exceeded the detection limit (&gt; 30,000 U/mL) by 2.3% on the fifth day, 12.2% on the sixth day, and 22.5% after the seventh day. Significant positive correlations were observed between the pre- and post-vaccination (the seventh and eighth days) antibody titers (correlation coefficient, 0.405; p &lt; 0.001). FWT is useful for examining antibody titers as a point-of-care test. Rapid response of antibody titer started as early as the fourth day post-vaccination, while the presence of weak responders to BNT162b2 vaccine was indicated.

DOI： 10.1038/s41598-022-24464-3

researchmap

Other Link： https://www.nature.com/articles/s41598-022-24464-3

Language：English   Publishing type：Research paper (scientific journal)   Publisher：Wiley  

DOI： 10.1002/ccr3.6652

researchmap

Other Link： https://onlinelibrary.wiley.com/doi/full-xml/10.1002/ccr3.6652

Language：English   Publishing type：Research paper (scientific journal)  

AIM: An increasing number of older adults in Japan are at an increased risk of road traffic crashes. This study aimed to investigate the prevalence of potential underlying medical factors that increase the risk of road traffic crashes among older people. METHODS: This cross-sectional observational study was conducted in 11 medical institutions in Japan using self-administered questionnaires and physical examination from January to May 2021. The background and social data, data on the use of nursing care insurance, and clinical data suggestive of polypharmacy, sarcopenia, cognitive impairment, and frailty/oral frailty were obtained. The prevalence of these factors was compared between everyday and occasional drivers. RESULTS: Data of 127 patients were collected; their median (interquartile range) age was 73 (70-78) years. Of the total participants, 82 were men (64.6%) and 45 were women (35.4%). There were 77 everyday drivers and 50 occasional drivers. Of these, 121 (95.3%) had not applied for nursing care insurance, but the numbers of those who required help 1 and 2 were 1 (0.8%) and 3 (2.4%), respectively. Prevalence of medical factors was as follows: polypharmacy, 27.6%; sarcopenia, 8.7%; dementia, 16.4%; frailty, 15.0%; and oral frailty, 54.3%; it was not significantly different between every day and occasional drivers. Intention to return the car license was significantly higher among the occasional drivers (2.6% vs. 14.0%; odds ratio: 6.7, 95% confidence interval: 1.2-70.6, p = 0.024). CONCLUSION: We uncovered the prevalence of medical factors that can be associated with road traffic crashes among Japanese older people aged ≥ 65 years in our community.

DOI： 10.1186/s12877-022-03490-w

PubMed

researchmap

Language：English   Publishing type：Research paper (scientific journal)  

Background and Objectives: Changes in post COVID-19 condition (PCC) characteristics caused by viral variants have yet to be clarified. We aimed to characterize the differences between clinical backgrounds and manifestations in long COVID patients who were infected with the Delta variant and those who were infected with the Omicron variants. Materials and Methods: This study was a single-center retrospective observational study for patients who visited our COVID-19 aftercare outpatient clinic (CAC) established in Okayama University Hospital (Japan) during the period from 15 February 2021 to 15 July 2022. We classified the onset of COVID-19 in the patients into three groups, the preceding, Delta-dominant, and Omicron-dominant periods, based on the prevalent periods of the variants in our prefecture. Results: In a total of 353 patients, after excluding 8 patients, 110, 130, and 113 patients were classified into the preceding, Delta-dominant, and Omicron-dominant periods, respectively. Patients infected in the Omicron-dominant period had significantly fewer hospitalizations, milder illnesses, more vaccinations and earlier visit to the CAC than did patients infected in the Delta-dominant period. Patients infected in the Omicron-dominant period had significantly lower frequencies of dysosmia (12% vs. 45%, ** p &lt; 0.01), dysgeusia (14% vs. 40%, ** p &lt; 0.01) and hair loss (7% vs. 28%, ** p &lt; 0.01) but had higher frequencies of fatigue (65% vs. 50%, * p &lt; 0.05), insomnia (26% vs. 13%, * p &lt; 0.05) and cough (20% vs. 7%, ** p &lt; 0.01) than did patients infected in the Delta-dominant period. Conclusions: The transitional changes in long COVID symptoms caused by the two variants were characterized.

DOI： 10.3390/medicina58101393

PubMed

researchmap

Language：English   Publishing type：Research paper (scientific journal)  

Candida dubliniensis phenotypically mimics Candida albicans in its microbiological features; thus, its clinical characteristics have yet to be fully elucidated. Here we report the case of a 68-year-old Japanese man who developed C. dubliniensis fungemia during treatment for severe coronavirus disease 2019 (COVID-19). The patient was intubated and received a combination of immunosuppressants, including high-dose methylprednisolone and two doses of tocilizumab, as well as remdesivir, intravenous heparin, and ceftriaxone. A blood culture on admission day 11 revealed Candida species, which was confirmed as C. dubliniensis by mass spectrometry. An additional sequencing analysis of the 26S rDNA and ITS regions confirmed that the organism was 100% identical to the reference strain of C. dubliniensis (ATCC MYA-646). Considering the simultaneous isolation of C. dubliniensis from a sputum sample, the lower respiratory tract could be an entry point for candidemia. Although treatment with micafungin successfully eradicated the C. dubliniensis fungemia, the patient died of COVID-19 progression. In this case, aggressive immunosuppressive therapy could have caused the C. dubliniensis fungemia. Due to insufficient clinical reports on C. dubliniensis infection based on definitive diagnosis, the whole picture of the cryptic organism is still unknown. Further accumulation of clinical and microbiological data of the pathogen is needed to elucidate their clinical significance.

DOI： 10.1016/j.jiac.2022.07.007

PubMed

researchmap

Language：English   Publishing type：Research paper (scientific journal)  

Orexin plays a key role in the regulation of sleep and wakefulness and in feeding behavior in the central nervous system, but its receptors are expressed in various peripheral tissues including endocrine tissues. In the present study, we elucidated the effects of orexin on pituitary gonadotropin regulation by focusing on the functional involvement of bone morphogenetic proteins (BMPs) and clock genes using mouse gonadotrope LβT2 cells that express orexin type 1 (OX1R) and type 2 (OX2R) receptors. Treatments with orexin A enhanced LHβ and FSHβ mRNA expression in a dose-dependent manner in the absence of GnRH, whereas orexin A in turn suppressed GnRH-induced gonadotropin expression in LβT2 cells. Orexin A downregulated GnRH receptor expression, while GnRH enhanced OX1R and OX2R mRNA expression. Treatments with orexin A as well as GnRH increased the mRNA levels of Bmal1 and Clock, which are oscillational regulators for gonadotropin expression. Of note, treatments with BMP-6 and -15 enhanced OX1R and OX2R mRNA expression with upregulation of clock gene expression. On the other hand, orexin A enhanced BMP receptor signaling of Smad1/5/9 phosphorylation through upregulation of ALK-2/BMPRII among the BMP receptors expressed in LβT2 cells. Collectively, the results indicate that orexin regulates gonadotropin expression via clock gene expression by mutually interacting with GnRH action and the pituitary BMP system in gonadotrope cells.

DOI： 10.3390/ijms23179782

PubMed

researchmap

Language：English  

We presented a case of primary bone lymphoma (PBL) which demonstrated fever of unknown origin. Although the diagnosis of PBL is difficult, up to 11% of patients with fever of unknown origin were later diagnosed with PBL, which suggests that there may be many cases of misdiagnosis. This case study emphasizes the importance of careful diagnosis for fever of unknown origin especially when the patient has bone pain.

DOI： 10.1002/jgf2.529

PubMed

researchmap

Language：English   Publishing type：Research paper (scientific journal)  

Background and Objectives: COVID-19 can be serious not only in the acute phase but also after the acute phase and some patients develop ME/CFS. There have been few studies on patients with long COVID in whom ME/CFS was diagnosed by physicians based on standardized criteria after examinations and exclusion diagnosis and not based on only subjective symptoms. The purpose of this study was to elucidate the detailed characteristics of ME/CFS in patients with long COVID. Materials and Methods: A retrospective descriptive study was performed for patients who visited a COVID-19 aftercare clinic established in Okayama University Hospital during the period was from February 2021 to April 2022. Results: Clinical data were obtained from medical records for 281 patients, and 279 patients who met the definition of long COVID were included. The overall prevalence rate of ME/CFS diagnosed by three sets of ME/CFS criteria (Fukuda, Canadian and IOM criteria) was 16.8% (48.9% in male and 51.1% in females). The most frequent symptoms in ME/CFS patients were general fatigue and post-exertional malaise (89.4% of the patients), headache (34.0%), insomnia (23.4%), dysosmia (21.3%) and dysgeusia (19.1%). Dizziness, chest pain, insomnia and headache were characteristic symptoms related to ME/CFS. The male to female ratio in ME/CFS patients was equal in the present study, although ME/CFS was generally more common in women in previous studies. Given that patients with ME/CFS had more severe conditions in the acute phase of COVID-19, the severity of the acute infectious state might be involved in the pathophysiology of ME/CFS. Conclusions: The prevalence rate of ME/CFS and the characteristic sequelae in the long COVID condition were revealed in this study.

DOI： 10.3390/medicina58070850

PubMed

researchmap

Language：English   Publishing type：Research paper (scientific journal)  

DOI： 10.2169/internalmedicine.9313-22

PubMed

researchmap

Language：English   Publishing type：Research paper (scientific journal)  

Evidence regarding treatment for the acute phase of COVID-19 has been accumulating, but specific treatment for long COVID/post-COVID-19 condition has not yet been established. Treatment with herbal medicine might be one treatment option for long COVID, but there has been little research on the effectiveness of herbal medicine for long COVID. The aim of this study was to clarify the prescription patterns of Kampo medicines, which are herbal medicines that originated in China and were developed in Japan, for the treatment of general fatigue due to long COVID. A retrospective descriptive study was performed for patients who visited a COVID-19 aftercare clinic established in Okayama University Hospital during the period from Feb 2021 to Dec 2021 with a focus on symptoms accompanying general fatigue and prescriptions of Kampo medicine. Among the clinical data obtained from medical records of 195 patients, clinical data for 102 patients with general fatigue and accompanying symptoms were analyzed. The patients had various symptoms, and the most frequent symptoms accompanying general fatigue were dysosmia, dysgeusia, headache, insomnia, dyspnea, and hair loss. Prescriptions of Kampo medicine accounted for 24.1% of the total prescriptions (n = 609). The most frequently prescribed Kampo medicine was hochuekkito (71.6%) and other prescribed Kampo medicines were tokishakuyakusan, ryokeijutsukanto, juzentaihoto, hangekobokuto, kakkonto, ninjin'yoeito, goreisan, rikkunshito, and keishibukuryogan. Since the pathophysiology of general fatigue after an infectious disease is, in general, considered a qi deficiency in Kampo medicine, treatments with such compensation agents can be the major prescription as a complement for the qi. In conclusion, Kampo medicine can be one of the main pharmacological treatments for long COVID accompanying general fatigue.

DOI： 10.3390/medicina58060730

PubMed

researchmap

Language：English   Publishing type：Research paper (scientific journal)  

Urinary catecholamines (CAs) have been examined for the screening of pheochromocytomas. The decision to perform screening is based on symptoms suggesting secondary hypertension or hyperactivities of the sympathetic nervous system. To elucidate the usefulness of urinary fractions and ratios of CAs, 79 patients in whom 24-h excretions of urinary CAs including adrenaline (AD), noradrenaline (NA) and dopamine (DA) had been examined from 2015 until 2020 were retrospectively analyzed. There were no significant differences in urinary CA levels between two age groups, gender groups and two BMI groups. Patients with histories of preexisting hypertension and diabetes showed significantly higher levels of urinary NA excretion, and the urinary ratio of NA/DA was also increased in the patients with a history of hypertension. Heart rate (HR) was significantly correlated with the urinary ratio of NA/DA. Serum free thyroxine (FT4) concentration and ratio of FT4/thyrotropin (TSH) were correlated with the level of urinary AD. The levels of TSH and FT4/TSH showed negative and positive correlations, respectively, with the urinary NA/DA ratio. Thus, increases of HR are related to the enhanced conversion of DA to NA and increased thyroid hormones are involved in the increase in urinary AD and the conversion of DA to NA. History of lifestyle-related diseases and changes of HR and thyroid functions need to be considered for the evaluation of urinary CAs and their ratios.

DOI： 10.1507/endocrj.EJ21-0488

PubMed

researchmap

Language：English   Publishing type：Research paper (scientific journal)  

Symptoms of long COVID are complex and long-lasting, and endocrine dysfunction might be involved in the underlying mechanisms. In this study, to clarify the hormonal characteristics of long COVID patients, laboratory data for patients who visited the outpatient clinic for long COVID were evaluated. A retrospective analysis was performed for patients who visited Okayama University Hospital during the period from Feb 2021 to Dec 2021 with focus on the interrelationships between major symptoms and endocrine data. Information and laboratory data were obtained from medical records for 186 patients. The patients had various symptoms, and the most frequent symptoms were general malaise, dysosmia/dysgeusia, hair loss, headache, dyspnea, and sleeplessness. Patients who were suffering from fatigue and dysosmia/dysgeusia were younger, while hair loss was more frequent in older and female patients. As for the characteristics of patients suffering from general fatigue, the scores of depression and fatigue were positively correlated with serum levels of cortisol and free thyroxin (FT4), respectively. Also, patients suffering from general fatigue had lower levels of serum growth hormone and higher levels of serum FT4, while patients with dysosmia/dysgeusia had a significantly lower level of serum cortisol. Serum thyrotropin (TSH) levels were higher and the ratios of FT4/TSH were lower in the initially severe cases, suggesting occult hypothyroidism. In addition, the ratios of plasma adrenocorticotropin to serum cortisol were decreased in patients with relatively high titers of serum SARS-CoV-2 antibody. Thus, hormonal changes seem to be, at least in part, involved in the persistent symptoms of long COVID.

DOI： 10.1507/endocrj.EJ22-0093

PubMed

researchmap

Language：English  

After the acute phase of COVID-19, some patients have been reported to have persistent symptoms including general fatigue. We have established a COVID-19 aftercare clinic (CAC) to provide care for an increasing number of these patients. Here, we report the case of a 36-year-old man who developed post-COVID fatigue after acute infection with SARS-CoV-2. In the acute phase of COVID-19, the patient's fever resolved within four days; however, general fatigue persisted for three months, and he visited our CAC 99 days after the initial infection. Examination revealed a high Aging Male's Symptoms (AMS) score of 44 and low free testosterone (FT) level of 5.5 pg/mL, which meet the Japanese criteria of late-onset hypogonadism (LOH) syndrome. Imaging studies revealed an atrophic pituitary in addition to fatty liver and low bone mineral density. Anterior pituitary function tests showed a low follicle-stimulating hormonelevel and delayed reaction of luteinizing hormone (LH) after gonadotropin-releasing hormone (GnRH) stimulation, indicating the possibility of hypothalamic hypogonadism in addition to primary hypogonadism seen in patients with post-COVID-19 conditions. After the initiation of Japanese traditional medicine (Kampo medicine: hochuekkito followed by juzentaihoto), the patient's symptoms as well as his AMS score and serum FT level were noticeably improved. Furthermore, follow-up tests of GnRH stimulation revealed improvements in LH responsiveness. Although many patients have been reported to meet the criteria of ME/CFS such as our case, we emphasize the possibility of other underlying pathologies including LOH syndrome. In conclusion, LOH syndrome should be considered a cause of general fatigue in patients with post-COVID-19 conditions and herbal treatment might be effective for long COVID symptoms due to LOH (264 words).

DOI： 10.3390/medicina58040536

PubMed

researchmap

Language：English   Publishing type：Research paper (scientific journal)  

To promote antimicrobial stewardship, we studied antimicrobial prescription rates for uncomplicated cystitis, a common outpatient disease requiring antibiotic treatment. This multicenter retrospective study was performed from January 1, 2018, to December 31, 2020, in Japan, targeting outpatients aged ≥ 20 years whose medical records revealed International Classification of Diseases (ICD-10) codes suggesting uncomplicated cystitis (N300). The data of 1445 patients were collected and that of 902 patients were analyzed. The overall median patient age was 71 years and a proportion of those aged less than 50 years was 18.8% with a female dominance (82.6%). Antimicrobials were prescribed for 884 patients (98.0%) and a total of 623 patients (69.1%) were treated with broad-spectrum drugs, including fluoroquinolones (36.0%), third-generation cephalosporins (29.9%) and faropenem (3.1%). A logistic regression model revealed that the broad-spectrum agents were significantly prescribed for the older patients, male patients, and those who visited internists. Recurrence was observed in 37 (4.1%) cases, and the multivariate analysis suggested any of age, sex, or antimicrobial types were not associated with the recurrence. Collectively, approximately two-thirds of antimicrobials prescribed for uncomplicated cystitis were broad-spectrum agents. The present data would be an indicator for antimicrobial prescriptions in uncomplicated cystitis in Japan.

DOI： 10.1038/s41598-022-09946-8

PubMed

researchmap

Publishing type：Research paper (scientific journal)   Publisher：Wiley  

DOI： 10.1002/ccr3.5713

researchmap

Other Link： https://onlinelibrary.wiley.com/doi/full-xml/10.1002/ccr3.5713

Language：English   Publishing type：Research paper (scientific journal)  

The pathogenesis and prognosis of post COVID-19 condition have remained unclear. We set up an outpatient clinic specializing in long COVID in February 2021 and we have been investigating post COVID-19 condition. Based on the results of our earlier study showing that "general fatigue" mimicking myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is the most common symptom in long COVID patients, a retrospective analysis was performed for 39 male patients in whom serum free testosterone (FT) levels were measured out of 61 male patients who visited our clinic. We analyzed the medical records of the patients' backgrounds, symptoms and laboratory results. Among the 39 patients, 19 patients (48.7%) met the criteria for late-onset hypogonadism (LOH; FT &lt; 8.5 pg/mL: LOH group) and 14 patients were under 50 years of age. A weak negative correlation was found between age and serum FT level (r = -0.301, p = 0.0624). Symptoms including general fatigue, anxiety, cough and hair loss were more frequent in the LOH group than in the non-LOH group (FT ≥ 8.5 pg/mL). Among various laboratory parameters, blood hemoglobin level was slightly, but significantly, lower in the LOH group. Serum level of FT was positively correlated with the levels of blood hemoglobin and serum total protein and albumin in the total population, whereas these interrelationships were blurred in the LOH group. Collectively, the results indicate that the incidence of LOH is relatively high in male patients, even young male patients, with post COVID-19 and that serum FT measurement is useful for revealing occult LOH status in patients with long COVID.

DOI： 10.3390/jcm11071955

PubMed

researchmap

Language：English   Publishing type：Research paper (scientific journal)  

BACKGROUND: Various symptoms persist even after the acute symptoms in about one third of patients with COVID-19. In February 2021, we established an outpatient clinic in a university hospital for patients with long COVID and started medical treatment for sequelae that persisted one month or more after infection. METHODS: To determine the key factors that affect the onset and clinical course of sequelae, a retrospective analysis was performed at Okayama University Hospital (Japan) between February and July 2021. We focused on changes in the numbers of symptoms and the background of the patients during a three-month period from the first outpatient visit. We also examined the relationship with SARS-CoV-2 antibody titers. RESULTS: Information was obtained from medical records for 65 patients. The symptoms of sequelae were diverse, with more than 20 types. The most frequent symptoms were general malaise, dysosmia, dysgeusia, sleeplessness, and headache. These symptoms improved in about 60% of the patients after 3 months. Patients who required hospitalization and had a poor condition in the acute phase and patients who received oxygen/dexamethasone therapy had higher antibody titers at the time of consultation. Patients with antibody titers ≥200 U/mL showed significantly fewer improvements in long COVID symptoms in 1 month, but they showed improvements at 3 months after the first visit. CONCLUSION: Long COVID symptoms were improved at 3 months after the initial visit in more than half of the patients. Serum antibody titers were higher in patients who experienced a severe acute phase, but the serum antibody titers did not seem to be directly related to the long-term persistence of long COVID symptoms.

DOI： 10.3390/jcm11051309

PubMed

researchmap

Language：English   Publishing type：Research paper (scientific journal)  

Subclinical hypothyroidism (SCH) is diagnosed when serum thyrotropin (TSH) is elevated despite a normal thyroxine level and is known to increase the risk of metabolic disorders. This study was conducted to identify potential laboratory markers suspicious for latent SCH. We retrospectively reviewed 958 outpatients in whom thyroid functions had been examined. Eighty-five (9.1%) of the 939 analyzed subjects had SCH (73% females). In the SCH group, median serum TSH and FT4 levels were 5.04 μU/ml and 1.19 ng/dl, respectively, and auto-thyroid antibodies were detected in 53.8% of patients. SCH group patients were significantly older than patients in the euthyroid group, while there was no intergroup difference in BMI. However, 56.5% of the SCH patients were asymptomatic. In the SCH group, serum aspartate aminotransferase and low-density lipoprotein cholesterol (LDL-C) levels were significantly higher, and the estimated glomerular filtration rate (eGFR) was significantly lower than in the euthyroid group. Among patients less than 65 years of age, SCH patients tended to have lower eGFR and higher LDL-C than euthyroid patients. Age-dependent reductions of red blood cells and serum albumin were more prominent in the SCH than the euthyroid group. Biochemical changes with aging are useful as potential clues for suspecting latent SCH.

DOI： 10.18926/AMO/63203

PubMed

researchmap

Language：English  

Herein, we report a remarkable case of post-coronavirus disease 2019 (COVID-19) diffuse alopecia that gradually improved and recovered, and the hair volume returned approximately to the pre-infection level, seven months after the patient's first diagnosis of COVID-19. Approximately 20% of patients with COVID-19 develop alopecia a few months after the acute infection phase. Telogen effluvium is the major type of COVID-19 sequela secondary to physical or psychological distress. It is reversible and is expected to improve without any treatment, and it can be addressed by explaining to the patients their conditions, sharing medical information, and eliminating psychophysical stress by managing systemic complications.

DOI： 10.7759/cureus.21160

PubMed

researchmap

Language：English   Publishing type：Research paper (scientific journal)  

Although ascites leakage to the skin is the most frequent complication after abdominal paracentesis, leakage to the subcutaneous space has not been reported. Here, we report a subcutaneous effusion after paracentesis suggesting ascites leakage. We should be aware of this rare complication due to the potential risk of dissemination.

DOI： 10.1002/ccr3.5116

PubMed

researchmap

Language：English   Publishing type：Research paper (scientific journal)  

DOI： 10.1136/bcr-2021-247123

PubMed

researchmap

Language：English   Publishing type：Research paper (scientific journal)  

DOI： 10.1093/rheumatology/keab799

PubMed

researchmap

Language：English   Publishing type：Research paper (scientific journal)  

To encourage and guide antimicrobial stewardship team (AST) activity and promote appropriate antibiotic use, we studied the impact of day of the week on the initiation and discontinuation of antibiotic administration. This was a multicenter observational study conducted at 8 Japanese hospitals from April 1 to September 30, 2019, targeting patients who underwent treatment with broad-spectrum antibiotics, such as anti-methicillin-resistant Staphylococcus aureus agents and anti-pseudomonal agents. We compared the weekly numbers of initiations and discontinuations of antibiotic prescription on each day of the week or on the days after a holiday. There was no statistical difference in the number of antibiotic initiations on both weekdays and the day after a holiday. However, antibiotic discontinuation was significantly higher from Tuesday onward than Monday and from the second day than the first day after a holiday. Similar trends were observed regardless of the categories of antibiotics, hospital and admission ward, and AST activity. This study suggests that broad-spectrum antibiotics tend to be continued during weekends and holidays and are most likely to be discontinued on Tuesday or the second day after a holiday. This was probably due to behavioral factors beyond medical indications, requiring further antimicrobial stewardship efforts in the future.

DOI： 10.1038/s41598-021-00206-9

PubMed

researchmap

Language：English   Publishing type：Research paper (scientific journal)  

Roles of Clock genes and the bone morphogenetic protein (BMP) system in the regulation of gonadotropin secretion by gonadotropin-releasing hormone (GnRH) were investigated using mouse gonadotropin LβT2 cells. It was found that luteinizing hormone (LH)β mRNA expression level in LβT2 cells changed gradually over time, with LHβ expression being suppressed in the early phase up to 12 h and then elevated in the late phase 24 h after GnRH stimulation. In addition, the mRNA expression levels of Clock genes, including Bmal1, Clock, Per2, and Cry1, also showed temporal changes mimicking the pattern of LHβ expression in the presence and absence of GnRH. Notably, the expression levels of Bmal1 and Clock showed strong positive correlations with LHβ mRNA expression levels. Moreover, a functional link of the ERK signaling of mitogen-activated protein kinases (MAPKs) in the suppression of LHβ mRNA expression, as well as Bmal1 and Clock mRNA expression by GnRH at the early phase, was revealed. Inhibition of Bmal1 and Clock expression using siRNA was involved in the reduction in LHβ mRNA levels in the late phase 24 h after GnRH stimulation. Furthermore, in the presence of BMP-6 and -7, late-phase Bmal1 and LHβ mRNA expression after GnRH stimulation was significantly attenuated. Collectively, the results indicated that LH expression in gonadotrope cells exhibits Bmal1/Clock-dependent fluctuations under the influence of GnRH and that the fluctuations are regulated by ERK and BMPs in the early and late stages, respectively, in a phase-dependent manner after GnRH stimulation.

DOI： 10.3390/ijms222011186

PubMed

researchmap

Language：English   Publishing type：Research paper (scientific journal)  

Introduction The long-term clinical course, prognosis, and optimal management of symptoms and conditions after the acute phase of coronavirus disease 2019 (COVID-19) remain to be elucidated. The purpose of this study was to clarify the characteristics of patients referred to a COVID-19 aftercare (CAC) clinic established at a tertiary academic hospital in Japan. Methods This study was a descriptive case series study. All patients who visited the CAC clinic between February 15 and September 17 in 2021 were included. Patients' background, chief complaints, and clinical courses after the onset of COVID-19 were described. Results A total of 87 Japanese patients (median age, 40.0 years; interquartile range [IQR], 26.5-53.0 years; 52.9% women) were referred to the CAC clinic. The median interval between the onset of COVID-19 and the visit to the clinic was 79.0 (IQR, 52.5-112.0) days. Referral sources were hospitals (36 patients), clinics (47 patients), a local healthcare center (3 patients), and other (1 patient). The most common chief complaint was general fatigue (50.4%) followed by dysosmia (28.7%), dysgeusia (26.4%), hair loss (18.4%), headache (17.2%), dyspnea (16.1%), and dyssomnia (13.1%). Respiratory symptoms were common in the early stages of the disease but were less common as the chief complaints when visiting the clinic. On the other hand, neurological, psychiatric, and extremity symptoms were predominant one month after the onset of COVID-19. Conclusions Regardless of the severity in the acute phase, patients visiting our CAC clinic suffered from a variety of symptoms. General physicians skilled in using a comprehensive approach would be optimal to see patients with such complex symptoms.

DOI： 10.7759/cureus.18568

PubMed

researchmap

Language：Japanese   Publisher：(公社)日本医師会  

国際化を背景に、在日外国人も新型コロナウイルス感染症(COVID-19)に罹患しているが、本邦でその診療上の課題に関する文献はない。2020年2月からの1年間に岡山大学病院総合内科・総合診療科に入院した、外国人COVID-19患者全5人を対象として、患者背景や言語状況、入院中のトラブルや解決策について診療録から抽出した。全員が日本語の書字・読字が全く不能であり、うち1人は日常会話も困難で電話医療通訳サービスを要したが、担当医や看護師に加えて、国際診療支援センターや臨床栄養部、精神科などと連携することで隔離解除まで入院継続が可能であった。COVID-19では本人の希望に沿わない入院や予定外入院のため、通常の外国人診療に比して負担・課題が大きい。特に言語面での制約は、隔離管理下での意思疎通や同意書の取得などの面で障壁となることが明らかとなった。院内組織の連携と、病院を超えた情報共有による病軟な対応が重要である。(著者抄録)

researchmap

Language：English   Publishing type：Research paper (scientific journal)   Publisher：CUREUS INC  

Y ObjectivesVitamin D deficiency, which is common worldwide, increases the risks of falls and fractures and can lead to increased morbidity and mortality. However, the clinical utility and relevance of vitamin D activation remain unknown. The aim of the present study was to clarify the clinical usefulness of serum 1,25-dihydroxyvitamin D (1,25D)/25-hydroxyvitamin D (25D) ratio for assessment of the extent of bone metabolism.MethodsWe retrospectively screened data for 87 patients whose serum 1,25D and 25D levels were measured. Eight patients who were taking vitamin D preparations were excluded, and data for 79 patients (33 males and 46 females) were analyzed. Since menopausal status can be associated with serum vitamin D level, we divided the patients by gender and divided the female patients into two groups at the age of 50 years.ResultsThe median serum 1,25D/25D ratio was significantly lower in males than in females, with the most considerable difference in all males [4.1 (interquartile range: 2.3-5.8) x 10(-3)] versus elderly females (aged >= 50 years) [7.9 (3.3-10.1) x 10(-3)). Main disorders were endocrine (30.6%), inflammatory (18.5%), and bone related (16.7%) disorders. The ratios of serum 1,25D/25D had significant negative correlations with femoral dual-energy X-ray absorptiometry % young adult mean (DEXA %YAM) (R=-0.35) and lumbar DEXA %YAM (R=-0.32). Significant correlations were found between the 1,25D/25D ratio and serum levels of inorganic phosphate (iP), parathyroid hormone, and alkaline phosphatase (ALP). The 1,25D/25D ratio had gender specific characteristics: the ratio was significantly correlated with age in males (R=-0.49), while it was significantly correlated with BMI in females (R=0.34).ConclusionsThe results of this study suggested that vitamin D activity is negatively correlated with bone mineral density, being reduced in aged males but enhanced in obese females.

DOI： 10.7759/cureus.18070

Web of Science

researchmap

Language：English   Publishing type：Research paper (scientific journal)  

The gold standard for the diagnosis of coronavirus disease 2019 (COVID-19) is a nucleic acid detection test for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which may occasionally reveal false-positive or false-negative results. Herein, we describe a case of a patient infected with human coronavirus NL63 (HCoV-NL63) who was falsely diagnosed with COVID-19 using the Ampdirect™ 2019-nCoV detection kit (Shimadzu Corporation, Japan) and SARS-CoV-2 Detection Kit (TOYOBO co., ltd.), and was admitted to a COVID-19 hospital ward. We suspected a cross-reaction between HCoV-NL63 and SARS-CoV-2; however, the reported genome sequences of HCoV-NL63 and N1/N2 primers for SARS-CoV-2 do not correspond. Thus, the PCR result was supposed to be a false positive possibly due to contamination or human error. Although the issue of a false-negative result has been the focus of much attention to prevent the spread of the disease, a false positive is fraught with problems as well. Physicians should recognize that unnecessary isolation violates human rights and a careful diagnosis is indispensable when the results of laboratory testing for COVID-19 are unclear. Generally, in cases such as a duplicate PCR test was partially positive, either N1 or N2 alone was positive, PCR testing for two or more target regions resulted in a positive only for single region, a high cycle threshold >35 was obtained, a false positive should be suspected. Especially, when these conditions coincide, we should recognize the high likelihood of a false positive.

DOI： 10.1016/j.jiac.2021.05.001

PubMed

researchmap

Language：English   Publishing type：Research paper (scientific journal)  

We have presented a case of barium appendicitis, which is a rare complication of barium enema studies. Barium sulfate is used widely for gastrointestinal radiographic studies and is associated with few complications. Clinicians need to be fully aware of this complication.

DOI： 10.1002/ccr3.4583

PubMed

researchmap

Language：English  

DOI： 10.1038/s41440-021-00633-1

PubMed

researchmap

Language：English   Publishing type：Research paper (scientific journal)  

The functional role of the transcription factors NR5A1 and NR5A2 and their interaction with Clock gene and bone morphogenetic proteins (BMPs) were investigated in human granulosa KGN cells. Treatment with BMP-15 and GDF-9 suppressed forskolin (FSK)-induced steroidogenesis as shown by the mRNA expression levels of StAR and P450scc but not the mRNA expression level of P450arom. Of interest, treatment with BMP-15 and GDF-9 also suppressed FSK-induced NR5A2 mRNA expression. Treatment with BMP-15 suppressed NR5A2 mRNA and protein expression but increased Clock mRNA and protein expression levels by granulosa cells. The mRNA expression levels of NR5A1, but not those of NR5A2, were positively correlated with the levels of Clock mRNA, while the mRNA levels of Id-1, the target gene of BMP signaling, were positively correlated with those of NR5A1 but not with those of NR5A2. It was also demonstrated that the mRNA expression levels of NR5A1 were positively correlated with those of P450arom and 3βHSD, whereas the mRNA expression level of NR5A2 was correlated with those of StAR and P450scc. Furthermore, inhibition of Clock gene expression by siRNA attenuated the expression of NR5A1, and the mRNA levels of Clock gene were significantly correlated with those of NR5A1. Collectively, the results suggested a novel mechanism by which Clock gene expression induced by BMP-15 is functionally linked to the expression of NR5A1, whereas NR5A2 expression is suppressed by BMP-15 in granulosa cells. The interaction between Clock NR5A1/NR5A2 and BMP-15 is likely to be involved in the fine-tuning of steroidogenesis by ovarian granulosa cells.

DOI： 10.1507/endocrj.EJ21-0223

PubMed

researchmap

Language：English   Publishing type：Research paper (scientific journal)  

To elucidate the impact of glucocorticoids on ovarian steroidogenesis and its molecular mechanism by focusing on bone morphogenetic proteins (BMPs), we examined the effect of dexamethasone (Dex) on estradiol and progesterone synthesis by using primary culture of rat granulosa cells. It was revealed that Dex treatment dose-dependently decreased estradiol production but increased progesterone production induced by follicle-stimulating hormone (FSH) by granulosa cells. In accordance with the effects of Dex on estradiol synthesis, Dex suppressed P450arom mRNA expression and cAMP synthesis induced by FSH. Dex treatment in turn enhanced basal as well as FSH-induced levels of mRNAs encoding the enzymes for progesterone synthesis including P450scc and 3βHSD but not StAR and 20αHSD. Of note, Dex treatment significantly upregulated transcription of the BMP target gene Id-1 and Smad1/5/9 phosphorylation in the presence of BMP-15 among the key ovarian BMP ligands. It was also found that Dex treatment increased the expression level of BMP type-I receptor ALK-6 among the type-I and -II receptors for BMP-15. Inhibitory Smad6/7 expression was not affected by Dex treatment. On the other hand, BMP-15 treatment upregulated glucocorticoid receptor (GR) expression in granulosa cells. Collectively, it was revealed that glucocorticoids elicit differential effects on ovarian steroidogenesis, in which GR and BMP-15 actions are mutually enhanced in granulosa cells.

DOI： 10.1016/j.bbrc.2021.04.085

PubMed

researchmap

Language：English   Publishing type：Research paper (scientific journal)  

DOI： 10.2169/internalmedicine.5946-20

PubMed

researchmap

Language：English  

DOI： 10.1111/ggi.14159

PubMed

researchmap

Language：English   Publishing type：Research paper (scientific journal)  

OBJECTIVE: Urinary free cortisol (UFC) is a reliable marker to avoid cortisol fluctuation and the effects of binding proteins. However, UFC levels are affected by fluid intake and urine volume, and the normal levels range widely. METHODS: To discover the utility of the ratio of urinary cortisol to aldosterone excretions, 246 patients in whom daily excretions of UFC and aldosterone (UAC) were measured were retrospectively analyzed. RESULTS: The UFC/UAC ratio showed significant positive and negative correlations with the levels of serum cortisol (R=0.287) and aldosterone (R=-0.762), respectively. The UFC/UAC ratio increased with aging in female patients, while it was not altered by the level of BMI in either gender. Markers for metabolic and inflammatory status, including hemoglobin A1c (R=0.327), albumin (R=-0.331), C-reactive protein (R=0.317), ferritin (R=0.473), and D-dimer (R=0.569), showed correlations with the ratio of UFC/UAC that were more significant than the correlations with the serum level of cortisol or UFC alone. Of note, the UFC/UAC ratio was shown to be an indicator for the risk of diabetes (AUC: 0.765), hypoalbuminemia (0.839), hyper-CRPemia (0.748), and thrombophilia (0.824), in which the cut-off levels of the UFC/UAC ratio were around 12. CONCLUSION: The UFC/UAC ratio is a variable for detecting metabolic and inflammatory complications related to adrenocortical dysfunction.

PubMed

researchmap

Language：English   Publishing type：Research paper (scientific journal)  

researchmap

Language：English   Publishing type：Research paper (scientific journal)  

DOI： 10.2169/internalmedicine.5856-20

PubMed

researchmap

Language：English  

Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) mainly affects young adults and can have a potential impact on social functioning. As this syndrome is associated with endothelial dysfunction, the heart can be damaged via ischemia due to endothelial damage. This might potentially lead to heart failure, which accounts for approximately 20% of deaths among patients with ME/CFS. While cardiac ischemia is thought be a pathophysiologically important manifestation of this syndrome, this is not yet reported. Herein, we present a case of a young female with newly diagnosed vasospastic or microvascular angina and concurrent exacerbation of ME/CFS severity. Her anginal symptoms, including exertional chest pain and transient chest discomfort, mimicked those of ME/CFS but were relieved after the administration of a calcium channel blocker. We emphasize the possibility of concurrent angina and exacerbation of ME/CFS and the importance of detecting cardiac ischemia to avoid unfavorable outcomes.

DOI： 10.3390/diagnostics11030460

PubMed

researchmap

Language：English   Publishing type：Research paper (scientific journal)  

Physicians should be aware of the risk of malignancy in patients with toxic multinodular goiter. Radionuclide scan cannot be used to predict the malignant potential of thyroid nodules. A comprehensive evaluation of imaging studies is needed.

DOI： 10.1002/ccr3.3843

PubMed

researchmap

Language：English   Publishing type：Research paper (scientific journal)  

A man who presented with a gingival tumor was finally diagnosed with angiosarcoma. It is important for primary care physicians to perform checkups of the oral cavity since oral lesions can lead to a diagnosis of serious systemic diseases.

DOI： 10.1002/jgf2.397

PubMed

researchmap

Language：English   Publishing type：Research paper (scientific journal)  

Functional interactions between the levels of clock gene expression and adrenal steroidogenesis were studied in human adrenocortical H295R cells. Fluctuations of Bmal1, Clock, Per2 and Cry1 mRNA levels were found in H295R cells treated with forskolin (FSK) in a serum-free condition. The changes of clock gene expression levels were diverged, with Clock mRNA level being significantly higher than Cry1 and Per2 mRNA levels after 12-h stimulation with FSK. After FSK induction, mRNA levels of StAR and CYP11B2 were highest at 12 hours and CYP17 mRNA level reached a peak at 6 hours, but HSD3B1 mRNA level was transiently decreased at 3 hours. The expression levels of Clock mRNA showed a significant positive correlation with StAR among the interrelationships between mRNA levels of key steroidogenic factors and clock genes. Knockdown of Clock gene by siRNA led to a significant reduction of FSK-induced expression of StAR and CYP17 after 12-h treatment with FSK. BMP-6 and activin, which modulate adrenal steroidogenesis, had inhibitory effects on Clock mRNA expression, whereas treatment with follistatin, a binding protein of activin, increased Clock mRNA levels in the presence of FSK, suggesting an endogenous function of activin in regulation of Clock mRNA expression. Collectively, the results indicated that changes of Clock mRNA expression, being upregulated by FSK and suppressed by BMP-6 and activin, were tightly linked to StAR expression by human adrenocortical cells.

DOI： 10.1507/endocrj.EJ20-0359

PubMed

researchmap

Language：English   Publishing type：Research paper (scientific journal)  

Influenza potentially has a high mortality rate when it affects the elderly. We aimed to examine the differences in clinical manifestations in patients with influenza according to their age. This multicenter prospective study was performed in six medical institutions in Okayama and Kagawa prefectures (Japan). Between December 1, 2019 and March 31, 2020, we collected data on adult patients diagnosed with influenza type A, who were strat-ified into younger (20-49 years), middle-aged (50-64 years), and older groups (≥ 65 years). We compared the presence or absence of fever, respiratory symptoms, and extrapulmonary symptoms according to age group. In total, 203 patients (113, younger; 51, middle-aged; and 39, older) were eligible for the analysis. The maxi-mum body temperature and temperature at first physician visit in the older group were significantly lower than those in the younger group. The incidence of respiratory symptoms was not different among the three groups. Chills, muscle pain, and arthralgia as systemic symptoms were noted significantly more frequently in the younger (80.9%) and middle-aged (75.5%) groups than in the older group (51.3%) (p = 0.002). Fever and sys-temic symptoms were less likely to appear in older patients, possibly resulting in the delaying of hospital visits among older adults.

DOI： 10.18926/AMO/62769

PubMed

researchmap

Language：English   Publishing type：Research paper (scientific journal)  

Antimicrobial stewardship for outpatients with acute respiratory tract infections (ARTIs) should be urgently promoted in this era of antimicrobial resistance. Previous large-sample studies were based on administrative data and had limited reliability. We aimed to identify current antimicrobial prescription practices for ARTIs by directly basing on medical records. This multicenter retrospective study was performed from January to December in 2018, at five medical institutes in Japan. We targeted outpatients aged ≥18 years whose medical records revealed International Classification of Diseases (ICD-10) codes suggesting ARTIs. We divided the eligible cases into three age groups (18-64 years, 65-74 years, and ≥75 years). We defined broad-spectrum antimicrobials as third-generation cephalosporins, macrolides, fluoroquinolones, and faropenem. Primary and secondary outcomes were defined as the proportion of antimicrobial prescriptions for the common cold and other respiratory tract infections, respectively. Totally, data of 3,940 patients were collected. Of 2,914 patients with the common cold, 369 (12.7%) were prescribed antimicrobials. Overall, compared to patients aged ≥75 years (8.5%), those aged 18-64 years (16.6%) and those aged 65-74 years (12.1%) were frequently prescribed antimicrobials for the common cold (odds ratio [95% confidential interval]; 2.15 [1.64-2.82] and 1.49 [1.06-2.09], respectively). However, when limited to cases with a valid diagnosis of the common cold by incorporating clinical data, no statistical difference was observed among the age groups. Broad-spectrum antimicrobials accounted for 90.2% of the antimicrobials used for the common cold. Of 1,026 patients with other respiratory infections, 1,018 (99.2%) were bronchitis, of which antimicrobials were prescribed in 49.9% of the cases. Broad-spectrum antimicrobials were the main agents prescribed, accounting for nearly 90% of prescriptions in all age groups. Our data suggested a favorable practice of antimicrobial prescription for outpatients with ARTIs in terms of prescribing proportions, or quantitative aspect. However, the prescriptions were biased towards broad-spectrum antimicrobials, highlighting the need for further antimicrobial stewardship in the outpatient setting from a qualitative perspective.

DOI： 10.1371/journal.pone.0259633

PubMed

researchmap

Language：English   Publishing type：Research paper (scientific journal)  

DOI： 10.1136/bcr-2020-240075

PubMed

researchmap

Language：English   Publishing type：Research paper (scientific journal)  

Renal cysts are detected in one third of acromegaly patients, especially in uncontrolled cases. Clinicians should pay attention to unexpected infection of enlarged renal cysts in acromegaly patients.

DOI： 10.1002/ccr3.3108

PubMed

researchmap

Language：English   Publishing type：Research paper (scientific journal)  

Aldosterone (Aldo) is involved in various cardiovascular diseases such as hypertension and heart failure. Aldo levels are known to be increased in patients with polycystic ovary syndrome, and expression of the mineralocorticoid receptor (MR) has also been detected in the ovary. However, the effect of Aldo on reproductive function has yet to be elucidated. Here, we examined the effects of Aldo on follicular steroidogenesis using primary culture of rat granulosa cells by focusing on the ovarian bone morphogenetic protein (BMP) system acting as a luteinizing inhibitor. We found that Aldo treatment increased FSH-induced progesterone production in a concentration-responsive manner. Consistent with the effects on steroidogenesis, Aldo increased mRNA levels of progesterogenic factor and enzymes including StAR and P450scc, whereas Aldo failed to change FSH-induced estradiol and cAMP synthesis or P450arom expression by granulosa cells. Progesterone production and StAR expression induced by FSH and Aldo were reversed by co-treatment with spironolactone, suggesting the involvement of geonomic MR action. Aldo treatment attenuated Smad1/5/9 phosphorylation and Id1 transcription induced by BMP-6. Furthermore, Aldo enhanced the expression of inhibitory Smad6 in the presence of BMP-6. In addition, BMP-6 downregulated MR expression, while Aldo modulated the mRNA levels of endogenous BMP-6 and BMP type-II receptors, indicating the existence of a feedback loop between the BMP system and MR in granulosa cells. Collectively, the results indicated that Aldo predominantly enhances FSH-induced progesterone production by inhibiting BMP-Smad signaling, suggesting a novel role of Aldo in ovarian steroidogenesis and a functional link between MR and BMP pathways in granulosa cells.

DOI： 10.1016/j.jsbmb.2020.105738

PubMed

researchmap

Language：English   Publishing type：Research paper (scientific journal)  

Clinicians should recognize extrahepatic portosystemic shunt as a cause of refractory or intermittent hepatic encephalopathy. Treatment strategies should be individualized according to patients' anatomic and hemodynamic status.

DOI： 10.1002/ccr3.2986

PubMed

researchmap

Language：English   Publishing type：Research paper (scientific journal)  

Adrenocortical carcinoma (ACC) is a rare aggressive tumor originating from adrenocortical parenchymal cells and its incidence is approximately 1 per million population per year. An oncocytic ACC is a recently identified entity among the several known histopathological variants of ACC, which is characterized by oncocytic cells, and only a few cases in the available literature have reported this tumor. In contrast to conventional ACCs, oncocytic ACCs usually manifest as solitary lesions presenting in adults without any sex predilection. We report a case of a 70-year-old Japanese man who presented with an incidentally discovered retroperitoneal mass without any evidence of excessive corticosteroid secretion. Laboratory and imaging studies, as well as transgastric endoscopic ultrasound-guided fine needle aspiration failed to establish a definitive diagnosis. Thus, the patient underwent surgical resection of the left-sided peritoneal tumor. Weiss score was positive in 6/9 points and the tumor met two major criteria of the Lin-Weiss-Bisceglia (LWB) system leading to a diagnosis of an oncocytic variant of ACC. Based on our findings in this patient, we conclude that a combination of the Weiss and LWB criteria is required to determine the malignant potential of oncocytic adrenal tumors because ACCs and oncocytomas could be frequently indistinguishable. Careful histopathological examination is pivotal in confirming the oncocytic component in the lesion and hence definitive diagnosis of ACCs.

DOI： 10.1507/endocrj.EJ20-0024

PubMed

researchmap

Language：English   Publishing type：Research paper (scientific journal)  

Odontogenic infections, generally caused by dental caries and periodontal disease, can result in fatal illness. We herein report a 71-year-old Japanese woman with type 2 diabetes and hemodialysis who suffered from multiple dentofacial abscesses mainly caused by multidrug-resistant Streptococcus oralis. She complained of pain and swelling of her face, with an extraoral fistula from the left cheek. Following 3 surgical debridement procedures and partial mandibulectomy, in addition to 12 weeks of antimicrobial therapy, the multiple dentofacial abscesses were ameliorated. A combination of surgical and antimicrobial treatments following an early diagnosis is essential for reducing further complications.

DOI： 10.2169/internalmedicine.4283-20

PubMed

researchmap

Language：English   Publishing type：Research paper (scientific journal)  

Adrenal insufficiency patients are treated with glucocorticoid replacement therapy. However, mimicking the in vivo circadian rhythm of cortisol levels is challenging, and suboptimal replacement increases the risk of mortality from cardiovascular disease. We herein report a case of coronary spastic angina (CSA) with simultaneous low early-morning serum cortisol levels in a patient undergoing corticosteroid replacement therapy for primary adrenal insufficiency. Steroid therapy is reportedly effective for refractory angina, but underlying adrenal deficiency has never been revealed. Our case intimates the probable risk of CSA as a complication of relative adrenal insufficiency and highlights the effectiveness of dexamethasone in these patients.

DOI： 10.2169/internalmedicine.4337-19

PubMed

researchmap

Language：English   Publishing type：Research paper (scientific journal)  

DOI： 10.2169/internalmedicine.4029-19

PubMed

researchmap

Language：English   Publishing type：Research paper (scientific journal)  

DOI： 10.2169/internalmedicine.3655-19

PubMed

researchmap

Language：English   Publishing type：Research paper (scientific journal)  

DOI： 10.1097/RHU.0000000000000694

PubMed

researchmap

Language：English   Publishing type：Research paper (scientific journal)  

DOI： 10.2169/internalmedicine.1692-18

PubMed

researchmap

Language：English   Publishing type：Research paper (scientific journal)  

A functional link between clock gene expression and ovarian steroidogenesis was studied using human granulosa KGN cells. Similarities between changes in the mRNA and protein expression levels of Bmal1 and Clock and those of Per2 and Cry1 were found in KGN cells after treatment with forskolin. Among the interrelationships between the expression levels of clock and steroidogenic factors, Clock mRNA had a strongly positive correlation with P450arom and a negative correlation with 3βHSD. Knockdown of Clock gene by siRNA resulted in a significant reduction of estradiol production by inhibiting P450arom expression, while it induced a significant increase of progesterone production by upregulating 3βHSD in KGN cells treated with forskolin. Moreover, BMP-7 had an enhancing effect on the expression of Clock mRNA and protein in KGN cells. Thus, the expression levels of Clock, being upregulated by forskolin and BMP-7, were functionally linked to estradiol production and progesterone suppression by human granulosa cells.

DOI： 10.1507/endocrj.EJ18-0423

PubMed

researchmap

Language：English   Publishing type：Research paper (scientific journal)  

DOI： 10.2169/internalmedicine.1293-18

PubMed

researchmap

Language：English   Publishing type：Research paper (scientific journal)  

A 70-year-old woman who had suffered from aseptic meningitis complained of chronic headache after dental treatment including tooth extraction. She developed a fever and respiratory failure. Based on chest computed tomography and head magnetic resonance imaging (MRI), she was diagnosed with osteomyelitis in the clivus accompanying moderate pituitary involvement, cavernous sinus thrombosis and septic pulmonary embolism. Both of the causal bacteria, Fusobacterium nucleatum and Campylobacter rectus, were isolated from her blood. Dual infection leading to clival osteomyelitis and cavernous sinus thrombosis has not been reported. It is important to perform enhanced MRI and blood culture for patients with chronic headache related to dental treatment.

DOI： 10.2169/internalmedicine.1025-18

PubMed

researchmap

Language：English   Publishing type：Research paper (scientific journal)  

In the present study, we studied the effects of metformin and its interactions with the actions of bone morphogenetic proteins (BMPs) on ovarian steroidogenesis. It was revealed that metformin treatment enhanced progesterone production by human granulosa KGN cells and rat primary granulosa cells induced by forskolin and FSH, respectively. In human granulosa cells, it was found that metformin treatment suppressed phosphorylation of Smad1/5/9 activated by BMP-15 compared with that induced by other BMP ligands. Moreover, metformin treatment increased the expression of inhibitory Smad6, but not of that Smad7, in human granulosa cells, while metformin had no significant impact on the expression levels of BMP type-I and -II receptors. Thus, the mechanism by which metformin suppresses BMP-15-induced Smad1/5/9 phosphorylation is likely, at least in part, to be upregulation of inhibitory Smad6 expression in granulosa cells. The results suggest the existence of functional interaction between metformin and BMP signaling, in which metformin enhances progesterone production by downregulating endogenous BMP-15 activity in granulosa cells.

DOI： 10.1016/j.bbrc.2018.07.058

PubMed

researchmap

Language：English   Publishing type：Research paper (scientific journal)  

The involvement of orexins in reproductive function has been gradually uncovered. However, the functional role of orexins in ovarian steroidogenesis remains unclear. In the present study, we investigated the effects of orexin A on ovarian steroidogenesis by using rat primary granulosa cells that express both OX1 and OX2 receptors for orexins. Treatment with orexin A enhanced progesterone, but not estradiol, biosynthesis induced by FSH, whereas it did not affect basal levels of progesterone or estradiol. In accordance with the effects on steroidogenesis, orexin A increased the mRNA levels of progesterogenic enzymes, including StAR, P450scc and 3βHSD, but not P450arom, and cellular cAMP synthesis induced by FSH. Under the condition of blockage of endogenous BMP actions by noggin or BMP-signaling inhibitors, orexin A failed to increase levels of progesterone synthesis induced by FSH treatment, suggesting that endogenous BMP activity in granulosa cells might be involved in the enhancement of progesterone synthesis by orexin A. Treatment with orexin A impaired Smad1/5/9 activation as well as Id-1 mRNA expression stimulated by BMP-6 and BMP-7, the latter of which was reversed by treatment with an OX1 antagonist. It was also found that orexin A suppressed the mRNA expression of both type-I and -II receptors for BMPs and increased that of inhibitory Smad6 and Smad7 in granulosa cells. On the other hand, treatments with BMP-6 and -7 suppressed the expression of OX1 and OX2. Collectively, the results indicated that orexin A enhances FSH-induced progesterone production, at least in part, by downregulating BMP signaling in granulosa cells. Thus, a new role of orexin A in facilitating progesterone synthesis and functional interaction between the orexin and BMP systems in granulosa cells were revealed.

DOI： 10.1016/j.jsbmb.2018.03.004

PubMed

researchmap

Language：English   Publishing type：Research paper (scientific journal)  

researchmap

Total pages：xxvii, 315p   Language：Japanese

CiNii Books

researchmap

Total pages：349p   Language：Japanese

CiNii Books

researchmap

Total pages：ix, 405p   Language：Japanese

CiNii Books

researchmap

Total pages：iv,369p   Language：Japanese

CiNii Books

researchmap

Language：Japanese   Publisher：(株)メディカル・サイエンス・インターナショナル  

＜文献概要＞key point ▼副甲状腺機能低下症を疑うきっかけは,低カルシウム(Ca)血症に伴う神経・筋症状が主であり,筋肉のつりやこむら返りなどの訴えに注意する。▼原因が明らかでない症例や治療時に血清Caを適切な濃度に保つことが難しい症例は,内分泌専門医に紹介する。▼内分泌専門医から管理を引き継いだ場合,活性型ビタミンD製剤の用量調節で神経・筋症状を抑えつつ,高Ca尿症による尿路結石の出現にも注意し,尿中Ca/クレアチニン比や血清Ca・リン積などを用いたモニタリングを行う。

researchmap

Language：Japanese   Publisher：(株)メディカル・サイエンス・インターナショナル  

＜文献概要＞key point ▼精神症状を呈する内分泌疾患は多く,精神症状が唯一の症状である場合もある。▼抑うつ症状をみたら,血糖,副腎,甲状腺,副甲状腺,性腺機能の異常を考える。▼男性では性腺機能低下症を,中年女性では更年期障害を想起する。

researchmap

Language：Japanese   Publisher：日本内科学会  

CiNii Article

CiNii Books

researchmap

Other Link： https://search.jamas.or.jp/link/ui/2021162863

J-GLOBAL

researchmap

J-GLOBAL

researchmap

Language：Japanese   Publisher：(一社)日本内科学会  

researchmap

Other Link： https://search.jamas.or.jp/index.php?module=Default&action=Link&pub_year=2020&ichushi_jid=J01159&link_issn=&doc_id=20200529140017&doc_link_id=10.2169%2Fnaika.109.1009&url=https%3A%2F%2Fdoi.org%2F10.2169%2Fnaika.109.1009&type=J-STAGE&icon=https%3A%2F%2Fjk04.jamas.or.jp%2Ficon%2F00007_3.gif

Event date： 2023.11.3 - 2023.11.4

Language：Japanese   Presentation type：Poster presentation  

researchmap

Event date： 2023.11.3 - 2023.11.4

Language：Japanese   Presentation type：Poster presentation  

researchmap

Event date： 2023.10.27 - 2023.10.28

Language：Japanese   Presentation type：Oral presentation (general)  

researchmap

Event date： 2023.10.27 - 2023.10.28

Language：Japanese   Presentation type：Oral presentation (general)  

researchmap

Event date： 2023.10.21

Language：Japanese   Presentation type：Oral presentation (general)  

researchmap

Event date： 2023.10.21

Language：Japanese   Presentation type：Oral presentation (general)  

researchmap

Event date： 2023.10.19 - 2023.10.21

Language：Japanese   Presentation type：Oral presentation (general)  

researchmap

Event date： 2023.8.26 - 2023.8.27

Language：Japanese   Presentation type：Oral presentation (general)  

researchmap

Event date： 2023.8.26 - 2023.8.27

Language：Japanese   Presentation type：Oral presentation (general)  

researchmap

Event date： 2023.8.3 - 2023.8.5

Language：Japanese   Presentation type：Oral presentation (general)  

researchmap

Event date： 2023.6.15 - 2023.6.18

Language：English   Presentation type：Poster presentation  

researchmap

Event date： 2023.6.1 - 2023.6.3

Language：Japanese   Presentation type：Oral presentation (general)  

researchmap

Event date： 2023.6.1 - 2023.6.3

Language：Japanese   Presentation type：Oral presentation (general)  

researchmap

Event date： 2023.6.1 - 2023.6.3

Language：English   Presentation type：Oral presentation (general)  

researchmap

Event date： 2023.6.1 - 2023.6.3

Language：English   Presentation type：Oral presentation (general)  

researchmap

Event date： 2023.6.1 - 2023.6.3

Language：Japanese   Presentation type：Poster presentation  

researchmap

Event date： 2023.5.21

Language：Japanese   Presentation type：Oral presentation (general)  

researchmap

Event date： 2023.5.21

Language：Japanese   Presentation type：Oral presentation (general)  

researchmap

Event date： 2023.5.21

Language：Japanese   Presentation type：Oral presentation (general)  

researchmap

Event date： 2023.5.21

Language：Japanese   Presentation type：Oral presentation (general)  

researchmap

Event date： 2023.4.14 - 2023.4.16

Language：Japanese   Presentation type：Oral presentation (general)  

researchmap

Event date： 2023.3.3 - 2023.3.4

Language：Japanese   Presentation type：Oral presentation (general)  

researchmap

Event date： 2023.2.25

Language：Japanese   Presentation type：Oral presentation (general)  

researchmap

Event date： 2023.2.18 - 2023.2.19

Language：Japanese   Presentation type：Oral presentation (general)  

researchmap

Event date： 2023.2.18 - 2023.2.19

Language：Japanese   Presentation type：Poster presentation  

researchmap

Event date： 2023.2.18 - 2023.2.19

Language：Japanese   Presentation type：Oral presentation (general)  

researchmap

Event date： 2023.2.11

Language：Japanese   Presentation type：Public lecture, seminar, tutorial, course, or other speech  

researchmap

Event date： 2022.12.17 - 2022.12.18

Language：Japanese   Presentation type：Oral presentation (general)  

researchmap

Event date： 2022.11.29

Language：Japanese   Presentation type：Public lecture, seminar, tutorial, course, or other speech  

researchmap

Event date： 2022.11.11 - 2022.11.12

Language：Japanese   Presentation type：Poster presentation  

researchmap

Event date： 2022.11.11 - 2022.11.12

Language：Japanese   Presentation type：Poster presentation  

researchmap

Event date： 2022.11.11 - 2022.11.12

Language：Japanese   Presentation type：Poster presentation  

researchmap

Event date： 2022.11.11 - 2022.11.12

Language：Japanese   Presentation type：Poster presentation  

researchmap

Event date： 2022.11.11 - 2022.11.12

Language：Japanese   Presentation type：Poster presentation  

researchmap

Event date： 2022.11.1 - 2022.11.3

Language：Japanese   Presentation type：Poster presentation  

researchmap

Event date： 2022.11.1 - 2022.11.3

Language：Japanese   Presentation type：Poster presentation  

researchmap

Event date： 2022.10.29 - 2022.10.30

Language：Japanese   Presentation type：Oral presentation (general)  

researchmap

Event date： 2022.10.29 - 2022.10.30

Language：Japanese   Presentation type：Oral presentation (general)  

researchmap

Event date： 2022.10.29 - 2022.10.30

Language：Japanese   Presentation type：Oral presentation (general)  

researchmap

Event date： 2022.9.3

Language：Japanese   Presentation type：Oral presentation (general)  

researchmap

Event date： 2022.9.3

Language：Japanese   Presentation type：Oral presentation (general)  

researchmap

Event date： 2022.8.19 - 2022.8.20

Language：Japanese   Presentation type：Oral presentation (general)  

researchmap

Event date： 2022.8.19 - 2022.8.20

Language：Japanese   Presentation type：Oral presentation (general)  

researchmap

Event date： 2022.8.19 - 2022.8.20

Language：Japanese   Presentation type：Oral presentation (general)  

researchmap

Event date： 2022.8.8 - 2022.8.10

Language：Japanese   Presentation type：Oral presentation (general)  

researchmap

Event date： 2022.6.11 - 2022.6.14

Language：English   Presentation type：Poster presentation  

researchmap

Event date： 2022.6.11 - 2022.6.14

Language：English   Presentation type：Poster presentation  

researchmap

Event date： 2022.6.11 - 2022.6.14

Language：English   Presentation type：Poster presentation  

researchmap

Event date： 2022.6.11 - 2022.6.14

Language：English   Presentation type：Poster presentation  

researchmap

Event date： 2022.6.10 - 2022.6.14

Language：English   Presentation type：Poster presentation  

researchmap

Event date： 2022.6.2 - 2022.6.4

Language：Japanese   Presentation type：Oral presentation (general)  

researchmap

Event date： 2022.6.2 - 2022.6.4

Language：Japanese   Presentation type：Oral presentation (general)  

researchmap

Event date： 2022.6.2 - 2022.6.4

Language：Japanese   Presentation type：Oral presentation (general)  

researchmap

Event date： 2022.6.2 - 2022.6.4

Language：Japanese   Presentation type：Oral presentation (general)  

researchmap

Event date： 2022.6.2 - 2022.6.4

Language：Japanese   Presentation type：Oral presentation (general)  

researchmap

Event date： 2022.6.2 - 2022.6.4

Language：Japanese   Presentation type：Oral presentation (general)  

researchmap

Event date： 2022.6.2 - 2022.6.4

Language：Japanese   Presentation type：Poster presentation  

researchmap

Event date： 2022.6.2 - 2022.6.4

Language：Japanese   Presentation type：Poster presentation  

researchmap

Event date： 2022.6.2 - 2022.6.4

Language：Japanese   Presentation type：Poster presentation  

researchmap

Event date： 2022.6.2 - 2022.6.4

Language：Japanese   Presentation type：Poster presentation  

researchmap

Event date： 2022.6.2 - 2022.6.4

Language：Japanese   Presentation type：Poster presentation  

researchmap

Event date： 2022.6.2 - 2022.6.4

Language：Japanese   Presentation type：Poster presentation  

researchmap

Event date： 2022.6.2 - 2022.6.4

Language：Japanese   Presentation type：Poster presentation  

researchmap

Event date： 2022.6.2 - 2022.6.4

Language：Japanese   Presentation type：Poster presentation  

researchmap

Event date： 2022.4.16

Language：Japanese   Presentation type：Oral presentation (general)  

researchmap

Event date： 2022.4.15 - 2022.4.17

Language：Japanese   Presentation type：Oral presentation (general)  

researchmap

Event date： 2022.4.15 - 2022.4.17

Language：Japanese   Presentation type：Poster presentation  

researchmap

Event date： 2022.4.15 - 2022.4.17

Language：Japanese   Presentation type：Poster presentation  

researchmap

Event date： 2022.4.9

Language：Japanese   Presentation type：Poster presentation  

researchmap

Event date： 2022.2.26 - 2022.2.27

Language：Japanese   Presentation type：Oral presentation (general)  

researchmap

Event date： 2022.2.26 - 2022.2.27

Language：Japanese   Presentation type：Oral presentation (general)  

researchmap

Event date： 2022.2.19

Language：Japanese   Presentation type：Oral presentation (general)  

researchmap

Event date： 2022.2.19

Language：Japanese   Presentation type：Oral presentation (general)  

researchmap

Event date： 2022.2.18 - 2022.2.19

Language：Japanese   Presentation type：Oral presentation (general)  

researchmap

Event date： 2022.2.9

Language：Japanese   Presentation type：Oral presentation (general)  

researchmap

Event date： 2022.2.9

Language：Japanese   Presentation type：Oral presentation (general)  

researchmap

Event date： 2022.1.8 - 2022.1.9

Language：Japanese   Presentation type：Oral presentation (general)  

researchmap

Event date： 2021.11.26 - 2021.11.27

Language：Japanese   Presentation type：Poster presentation  

researchmap

Event date： 2021.11.26 - 2021.11.27

Language：Japanese   Presentation type：Poster presentation  

researchmap

Event date： 2021.11.26 - 2021.11.27

Language：Japanese   Presentation type：Poster presentation  

researchmap

Event date： 2021.11.26 - 2021.11.27

Language：Japanese   Presentation type：Poster presentation  

researchmap

Event date： 2021.11.26 - 2021.11.27

Language：Japanese   Presentation type：Poster presentation  

researchmap

Event date： 2021.11.26 - 2021.11.27

Language：Japanese   Presentation type：Poster presentation  

researchmap

Event date： 2021.11.26 - 2021.11.27

Language：Japanese   Presentation type：Poster presentation  

researchmap

Event date： 2021.11.18 - 2021.11.20

Language：Japanese   Presentation type：Oral presentation (general)  

researchmap

Event date： 2021.11.6

Language：Japanese   Presentation type：Oral presentation (general)  

researchmap

Event date： 2021.11.6

Language：Japanese   Presentation type：Oral presentation (general)  

researchmap

Event date： 2021.10.30 - 2021.10.31

Language：Japanese   Presentation type：Oral presentation (general)  

researchmap

Event date： 2021.10.30 - 2021.10.31

Language：Japanese   Presentation type：Oral presentation (general)  

researchmap

Event date： 2021.10.22 - 2021.10.23

Language：Japanese   Presentation type：Oral presentation (general)  

researchmap

Event date： 2021.10.22 - 2021.10.23

Language：Japanese   Presentation type：Oral presentation (general)  

researchmap

Event date： 2021.9.4

Language：Japanese   Presentation type：Oral presentation (general)  

researchmap

Event date： 2021.9.4

Language：Japanese   Presentation type：Oral presentation (general)  

researchmap

Event date： 2021.9.4

Language：Japanese   Presentation type：Oral presentation (general)  

researchmap

Event date： 2021.8.19 - 2021.8.21

Language：Japanese   Presentation type：Oral presentation (general)  

researchmap

Event date： 2021.7.8 - 2021.7.10

Language：Japanese   Presentation type：Oral presentation (general)  

researchmap

Event date： 2021.7.8 - 2021.7.10

Language：Japanese   Presentation type：Oral presentation (general)  

researchmap

Event date： 2021.6.20

Language：Japanese   Presentation type：Oral presentation (general)  

researchmap

Event date： 2021.6.20

Language：Japanese   Presentation type：Oral presentation (general)  

researchmap

Event date： 2021.4.22 - 2021.4.24

Language：Japanese   Presentation type：Oral presentation (general)  

researchmap

Event date： 2021.4.22 - 2021.4.24

Language：Japanese   Presentation type：Poster presentation  

researchmap

Event date： 2021.4.22 - 2021.4.24

Language：Japanese   Presentation type：Poster presentation  

researchmap

Event date： 2021.4.22 - 2021.4.24

Language：Japanese   Presentation type：Poster presentation  

researchmap

Event date： 2021.4.22 - 2021.4.24

Language：Japanese   Presentation type：Poster presentation  

researchmap

Event date： 2021.4.22 - 2021.4.24

Language：Japanese   Presentation type：Poster presentation  

researchmap

Event date： 2021.4.22 - 2021.4.24

Language：Japanese   Presentation type：Poster presentation  

researchmap

Event date： 2021.4.22 - 2021.4.24

Language：Japanese   Presentation type：Oral presentation (general)  

researchmap

Event date： 2021.4.22 - 2021.4.24

Language：Japanese   Presentation type：Oral presentation (general)  

researchmap

Event date： 2021.4.22 - 2021.4.24

Language：Japanese   Presentation type：Poster presentation  

researchmap

Event date： 2021.4.22 - 2021.4.24

Language：Japanese   Presentation type：Poster presentation  

researchmap

Event date： 2021.4.22 - 2021.4.24

Language：Japanese   Presentation type：Poster presentation  

researchmap

Event date： 2021.4.10

Language：Japanese   Presentation type：Oral presentation (general)  

researchmap

Event date： 2021.3.20 - 2021.3.23

Language：English   Presentation type：Poster presentation  

researchmap

Event date： 2021.3.20 - 2021.3.23

Language：English   Presentation type：Poster presentation  

researchmap

Event date： 2021.3.20 - 2021.3.23

Language：English   Presentation type：Poster presentation  

researchmap

Event date： 2021.3.20 - 2021.3.23

Language：English   Presentation type：Poster presentation  

researchmap

Event date： 2021.2.27

Language：Japanese   Presentation type：Oral presentation (general)  

researchmap

Event date： 2021.2.27

Language：Japanese   Presentation type：Oral presentation (general)  

researchmap

Event date： 2021.2.27

Language：Japanese   Presentation type：Oral presentation (general)  

researchmap

Event date： 2021.2.19 - 2021.2.20

Language：Japanese   Presentation type：Oral presentation (general)  

researchmap

Event date： 2021.2.18 - 2021.2.19

Language：Japanese   Presentation type：Oral presentation (general)  

researchmap

Event date： 2021.2.18 - 2021.2.19

Language：Japanese   Presentation type：Oral presentation (general)  

researchmap

Event date： 2020.12.12 - 2020.12.25

Language：Japanese   Presentation type：Oral presentation (general)  

researchmap

Event date： 2020.11.13 - 2020.11.14

Language：Japanese   Presentation type：Poster presentation  

researchmap

Event date： 2020.11.13 - 2020.11.14

Language：Japanese   Presentation type：Oral presentation (general)  

researchmap

Event date： 2020.11.13 - 2020.11.14

Language：Japanese   Presentation type：Oral presentation (general)  

researchmap

Event date： 2020.11.13 - 2020.11.14

Language：Japanese   Presentation type：Poster presentation  

researchmap

Event date： 2020.11.13 - 2020.11.14

Language：Japanese   Presentation type：Oral presentation (general)  

researchmap

Event date： 2020.11.7 - 2020.11.8

Language：Japanese   Presentation type：Symposium, workshop panel (public)  

researchmap

Event date： 2020.10.23 - 2020.11.8

Language：Japanese   Presentation type：Oral presentation (general)  

researchmap

Event date： 2020.9.5

Language：Japanese   Presentation type：Oral presentation (general)  

researchmap

Event date： 2020.9.5

Language：Japanese   Presentation type：Oral presentation (general)  

researchmap

Event date： 2020.9.5

Language：Japanese   Presentation type：Oral presentation (general)  

researchmap

Event date： 2020.9.5

Language：Japanese   Presentation type：Oral presentation (general)  

researchmap

Event date： 2020.7.20 - 2020.8.31

Language：Japanese   Presentation type：Oral presentation (general)  

researchmap

Event date： 2020.7.20 - 2020.8.31

Language：Japanese   Presentation type：Oral presentation (general)  

researchmap

Event date： 2020.7.20 - 2020.8.31

Language：Japanese   Presentation type：Oral presentation (general)  

researchmap

Event date： 2020.7.20 - 2020.8.31

Language：Japanese   Presentation type：Oral presentation (general)  

researchmap

Event date： 2020.7.20 - 2020.8.31

Language：Japanese   Presentation type：Oral presentation (general)  

researchmap

Event date： 2020.7.20 - 2020.8.31

Language：Japanese   Presentation type：Oral presentation (general)  

researchmap

Event date： 2020.2.19

Language：Japanese   Presentation type：Oral presentation (general)  

researchmap

Event date： 2020.1.11 - 2020.1.12

Language：Japanese   Presentation type：Oral presentation (general)  

researchmap

Event date： 2019.11.29 - 2019.11.30

Language：Japanese   Presentation type：Poster presentation  

researchmap

Event date： 2019.11.29 - 2019.11.30

Language：Japanese   Presentation type：Poster presentation  

researchmap

Event date： 2019.11.29 - 2019.11.30

Language：Japanese   Presentation type：Poster presentation  

researchmap

Event date： 2019.11.2

Language：Japanese   Presentation type：Oral presentation (general)  

researchmap

Event date： 2019.10.5

Language：Japanese   Presentation type：Oral presentation (general)  

researchmap

Event date： 2019.10.5

Language：Japanese   Presentation type：Oral presentation (general)  

researchmap

Event date： 2019.10.5

Language：Japanese   Presentation type：Public lecture, seminar, tutorial, course, or other speech  

researchmap

Event date： 2019.9.14 - 2019.9.15

Language：Japanese   Presentation type：Oral presentation (general)  

researchmap

Event date： 2019.9.7

Language：Japanese   Presentation type：Oral presentation (general)  

researchmap

Event date： 2019.6.1

Language：Japanese   Presentation type：Oral presentation (general)  

researchmap

Event date： 2019.5.25

Language：Japanese   Presentation type：Oral presentation (general)  

researchmap

Event date： 2019.5.9 - 2019.5.11

Language：Japanese   Presentation type：Poster presentation  

researchmap

Event date： 2019.5.9 - 2019.5.11

Language：Japanese   Presentation type：Poster presentation  

researchmap

Event date： 2019.5.9 - 2019.5.11

Language：Japanese   Presentation type：Poster presentation  

researchmap

Event date： 2019.5.9 - 2019.5.11

Language：Japanese   Presentation type：Poster presentation  

researchmap

Event date： 2019.5.9 - 2019.5.11

Language：Japanese   Presentation type：Poster presentation  

researchmap

Event date： 2019.4.27

Language：Japanese   Presentation type：Poster presentation  

researchmap

Event date： 2019.3.23 - 2019.3.26

Language：English   Presentation type：Poster presentation  

researchmap

Event date： 2019.3.23 - 2019.3.26

Language：English   Presentation type：Poster presentation  

researchmap

Event date： 2019.3.23 - 2019.3.26

Language：English   Presentation type：Poster presentation  

researchmap

Event date： 2019.3.23 - 2019.3.26

Language：English   Presentation type：Poster presentation  

researchmap

Event date： 2019.2.15 - 2019.2.16

Language：Japanese   Presentation type：Oral presentation (general)  

researchmap

Event date： 2019.2.15 - 2019.2.16

Language：Japanese   Presentation type：Poster presentation  

researchmap

Event date： 2019.2.15 - 2019.2.16

Language：Japanese   Presentation type：Oral presentation (general)  

researchmap

Event date： 2018.12.14 - 2018.12.15

Language：Japanese   Presentation type：Oral presentation (general)  

researchmap

Event date： 2018.12.14 - 2018.12.15

Language：Japanese   Presentation type：Oral presentation (general)  

researchmap

Event date： 2018.12.14 - 2018.12.15

Language：Japanese   Presentation type：Oral presentation (general)  

researchmap

Event date： 2018.11.17

Language：Japanese   Presentation type：Oral presentation (general)  

researchmap

Event date： 2018.11.2 - 2018.11.3

Language：Japanese   Presentation type：Poster presentation  

researchmap

Event date： 2018.11.2 - 2018.11.3

Language：Japanese   Presentation type：Poster presentation  

researchmap

Event date： 2018.9.15 - 2018.9.16

Language：Japanese   Presentation type：Poster presentation  

researchmap

Event date： 2018.9.12

Language：Japanese   Presentation type：Oral presentation (general)  

researchmap

Event date： 2018.9.6 - 2018.9.7

Language：Japanese   Presentation type：Oral presentation (general)  

researchmap

Event date： 2018.8.17 - 2018.8.19

Language：Japanese   Presentation type：Oral presentation (general)  

researchmap

Event date： 2018.5.19

Language：Japanese   Presentation type：Oral presentation (general)  

researchmap

Event date： 2018.3.17 - 2018.3.20

Language：English   Presentation type：Poster presentation  

researchmap

Event date： 2018.3.2 - 2018.3.3

Language：Japanese   Presentation type：Poster presentation  

researchmap

Event date： 2018.3.2 - 2018.3.3

Language：Japanese   Presentation type：Poster presentation  

researchmap

Event date： 2018.3.2 - 2018.3.3

Language：Japanese   Presentation type：Poster presentation  

researchmap

Event date： 2018.2.3

Language：Japanese   Presentation type：Oral presentation (general)  

researchmap

Event date： 2017.9.14 - 2017.9.15

Language：Japanese   Presentation type：Poster presentation  

researchmap

Event date： 2017.6.3

Language：Japanese   Presentation type：Oral presentation (general)  

researchmap

Event date： 2015.7.4

Language：Japanese   Presentation type：Oral presentation (general)  

researchmap

researchmap